CANCER SCI 润色咨询

CANCER SCIENCE

出版年份:2003 年文章数:345 投稿命中率:45.94%

出版周期:Monthly 自引率:2.7% 审稿周期:平均1.74月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均1.74月 (网友贡献,非官方数据)
投稿命中率
45.94% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量34.20% (2018年为5.54%)
自引率
2.7 %
年文章数
345
期刊官网
点击查看 (点击次数:36374)
点击查看 (点击次数:29716次)
作者需知
点击查看 (点击次数:1201次)
期刊简介
稿件收录要求

Overview


Cancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer.   Subject categories include:

  • Basic and Clinical Immunology
  • Carcinogenesis
  • Cell, Molecular, and Stem Cell Biology
  • Clinical Research
  • Drug Discovery and Delivery
  • Epidemiology and Prevention
  • Genetics, Genomics, and Proteomics
  • Inflammation and Virology
  • Pathology

Aims and Scope


Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association.  First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.

Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor.  The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.

Effective from 1 January 2017, Cancer Science will not accept work that is funded in any part by tobacco industry sources.

Average submission to first decision is 17 days!


Readership


Offers access to members of Japan''''''''''''''''s leading oncology society, with 16,000 members


Keywords


oncology, cancer, Japanese Cancer Association, Cancer Science, cancer research, palliative care, radiotherapy


Abstracting and Indexing Information

  • AgBiotech News & Information (CABI)
  • BIOBASE: Current Awareness in Biological Sciences (Elsevier)
  • Biological Abstracts (Clarivate Analytics)
  • BIOSIS Previews (Clarivate Analytics)
  • CAS: Chemical Abstracts Service (ACS)
  • CSA Biological Sciences Database (ProQuest)
  • CSA Oncogenes & Growth Factors Abstracts (ProQuest)
  • Current Contents: Clinical Medicine (Clarivate Analytics)
  • Embase (Elsevier)
  • HEED: Health Economic Evaluations Database (Wiley-Blackwell)
  • InfoTrac (GALE Cengage)
  • Journal Citation Reports/Science Edition (Clarivate Analytics)
  • MEDLINE/PubMed (NLM)
  • PubMed Dietary Supplement Subset (NLM)
  • Science Citation Index (Clarivate Analytics)
  • Science Citation Index Expanded (Clarivate Analytics)
  • SCOPUS (Elsevier)